TherapeuticsMD Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Revenue	1.3	69.96	2.57	64.87	49.65	16.1	16.78	19.36	20.14	15.03	Upgrade
Revenue Growth (YoY)	-98.14%	2619.12%	-96.03%	30.67%	208.38%	-4.04%	-13.32%	-3.90%	34.05%	71.23%	Upgrade
Cost of Revenue	0	1.4	1.4	15.98	6.34	2.74	2.64	4.19	4.51	3.67	Upgrade
Gross Profit	1.3	68.57	1.17	48.9	43.31	13.36	14.14	15.17	15.64	11.35	Upgrade
Selling, General & Admin	8.9	56.71	80.75	194.01	174.73	115.99	57.7	51.35	28.72	22.12	Upgrade
Research & Development	0	0	0	10.43	19.79	27.3	33.85	53.94	72.04	43.22	Upgrade
Other Operating Expenses	0.92	10.67	0	0	0	0.29	0.21	0.13	0.06	0.05	Upgrade
Operating Expenses	9.83	67.38	80.75	204.44	194.52	143.58	91.77	105.42	100.83	65.4	Upgrade
Operating Income	-8.52	1.19	-79.58	-155.54	-151.21	-130.22	-77.63	-90.25	-85.19	-54.04	Upgrade
Interest Expense / Income	0	0	0	28.58	17.38	4.68	0	0	0	0	Upgrade
Other Expense / Income	1.8	-110.81	92.84	-0.6	7.56	-2.28	-0.7	-0.38	-0.11	0.18	Upgrade
Pretax Income	-10.32	112	-172.42	-183.52	-176.15	-132.62	-76.93	-89.88	-85.08	-54.22	Upgrade
Income Tax	-0.04	0	0	0	0	0	0	0	0	0	Upgrade
Net Income	-10.28	112	-172.42	-183.52	-176.15	-132.62	-76.93	-89.88	-85.08	-54.22	Upgrade
Shares Outstanding (Basic)	10	9	8	6	5	5	4	4	3	3	Upgrade
Shares Outstanding (Diluted)	10	9	8	6	5	5	4	4	3	3	Upgrade
Shares Change	11.48%	17.66%	44.39%	11.89%	9.48%	9.49%	4.81%	13.23%	15.66%	17.37%	Upgrade
EPS (Basic)	-0.98	12.41	-21.66	-33.50	-36.00	-29.50	-18.50	-23.00	-24.50	-18.00	Upgrade
EPS (Diluted)	-0.98	11.96	-21.66	-33.50	-36.00	-29.50	-18.50	-23.00	-24.50	-18.00	Upgrade
Free Cash Flow	-48.14	-4.08	-142.73	-159.68	-168.17	-107.03	-76.22	-69.54	-79.21	-45.55	Upgrade
Free Cash Flow Per Share	-4.61	-0.45	-17.93	-28.96	-34.13	-23.78	-18.54	-17.73	-22.87	-15.21	Upgrade
Gross Margin	100.00%	98.00%	45.51%	75.37%	87.24%	83.00%	84.28%	78.38%	77.63%	75.56%	Upgrade
Operating Margin	-654.61%	1.70%	-3092.77%	-239.77%	-304.56%	-808.85%	-462.69%	-466.27%	-422.93%	-359.65%	Upgrade
Profit Margin	-789.40%	160.08%	-6700.93%	-282.90%	-354.79%	-823.74%	-458.50%	-464.32%	-422.37%	-360.82%	Upgrade
Free Cash Flow Margin	-3697.47%	-5.83%	-5547.10%	-246.14%	-338.73%	-664.80%	-454.28%	-359.25%	-393.24%	-303.15%	Upgrade
EBITDA	-9.4	113.19	-171.68	-150.88	-157.37	-127.65	-76.71	-89.74	-85.01	-54.16	Upgrade
EBITDA Margin	-721.89%	161.79%	-6672.33%	-232.57%	-316.98%	-792.86%	-457.23%	-463.63%	-422.06%	-360.47%	Upgrade
Depreciation & Amortization	0.92	1.19	0.74	4.07	1.39	0.29	0.21	0.13	0.06	0.05	Upgrade
EBIT	-10.32	112	-172.42	-154.94	-158.76	-127.94	-76.93	-89.88	-85.08	-54.22	Upgrade
EBIT Margin	-792.70%	160.08%	-6700.93%	-238.84%	-319.78%	-794.68%	-458.50%	-464.32%	-422.37%	-360.82%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).